Drug profile · INN
teniposide
VUMON
teniposide (VUMON) is a dna topoisomerase ii inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — teniposide
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
teniposide (VUMON) is a dna topoisomerase ii inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
DNA topoisomerase II inhibitor
Primary target: DNA topoisomerase II
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| NMPA | clinical trials | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is teniposide?
teniposide (VUMON) is a dna topoisomerase ii inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for teniposide?
VUMON is a marketed brand name for teniposide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of teniposide?
teniposide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.